Pfizer (NYSE:PFE) discovers, develops, manufactures, markets, distributes and sells biopharmaceutical products in the United ...

Padcev, a drug Pfizer acquired in 2023, is a part of the only chemo-free treatment for bladder cancer patients newly ...

As was the case with Ares Capital and Enterprise Products Partners, Pfizer's dividend is firmly in ultra-high-yield territory. Its forward dividend yield tops 6.4%. Pfizer's management sounds ...

Maintaining dividend aristocrat status isn’t easy, as it requires companies to pay out dividends consistently (and raise them ...

I have selected Pfizer and Verizon as my top two high dividend yield companies to invest in for November 2024. Click here to ...

Pfizer's high initial dividend yield, solid ratings, and promising pipeline make it a potentially undervalued investment. See ...

Investors looking for a way to pump up their passive income streams want to turn their attention toward the pharmaceutical ...

Political uncertainty has created buying opportunities among blue-chip healthcare stocks with big-time dividends.

We recently compiled a list of the Dividend Contenders List: Top 15. In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against the other dividend contenders.

High-yield dividend stocks have been gaining momentum ahead of potential Fed rate cuts. Here's why these two high-yield ...